Skip to content
OpenCapital
Get started

Microvision MVIS Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value at other companies

Repligen logo
RepligenRGEN
$155.80—
AMN Healthcare logo
AMN HealthcareAMN
$80.79-9.9%
Kopin logo
KopinKOPN
$1.62—
Heartland Express logo
Heartland ExpressHTLD
$10.71-5.1%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$54.10+21.0%
Heartland Express logo
Heartland ExpressHTLD
$10.48-4.3%

Other financials

Income statement

See full
Revenue$935.0K+58.7%
Gross profit$363.0K+831%
Operating income-$23.5M-67.3%
Net income-$25.3M+12.1%
EPS (diluted)-$0.08+33.3%

Balance sheet

See full
Cash & equivalents$21.5M-59.8%
Total debt$53.4M+10.0%
Total equity$39.5M-25.7%
Total assets$110.2M-5.6%

Cash flow

See full
Operating cash flow-$16.4M-16.6%
CapEx$143.0K+44.4%
Free cash flow-$16.6M-16.8%

Valuation

See full
Market cap$112.7M-58.9%
Enterprise value$144.63M-42.0%
P/S72.5×-33.6×

Profitability

See full
Gross margin-1,095%-1,159pp
Operating margin-5,938.4%-9,823pp
Net margin-5,887.8%-16,314pp
FCF margin-3,976.1%-9,170pp

Returns & leverage

See full
Return on equity-197.3%+168pp
Debt / equity1.4×+0.4×
Current ratio1×-0.8×

Where this comes from

Reported directly by Microvision in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.

The official record: Microvision’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microvision's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Microvision's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value?
Microvision (MVIS) reported share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value of $1.2 in Q1 2026.
How has Microvision's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value changed year-over-year?
Microvision's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value decreased by 20.5% year-over-year, from $1.51 to $1.2.
What is the long-term trend for Microvision's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value?
Over 5 years (2020 to 2025), Microvision's share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value has grown at a 10.3% compound annual growth rate (CAGR), from $0.76 to $1.24.